Neuberger Berman Group
THC icon

Neuberger Berman Group’s Tenet Healthcare THC Stock Holding History

Neuberger Berman Group’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.23M Buy
44,006
+3,559
+9% +$654K 0.01% 930
2026
Q1 		$7.63M Buy
40,447
+15,224
+60% +$3.21M 0.01% 882
2025
Q4 		$5.01M Sell
25,223
-7,397
-23% -$1.49M ﹤0.01% 971
2025
Q3 		$6.62M Buy
32,620
+4,224
+15% +$749K ﹤0.01% 902
2025
Q2 		$5M Buy
28,396
+7,532
+36% +$1.13M ﹤0.01% 964
2025
Q1 		$2.81M Buy
20,864
+15,252
+272% +$2.01M ﹤0.01% 1054
2024
Q4 		$708K Buy
5,612
+60
+1% +$8.92K ﹤0.01% 1417
2024
Q3 		$923K Buy
5,552
+30
+0.5% +$4.54K ﹤0.01% 1321
2024
Q2 		$735K Buy
5,522
+253
+5% +$30.5K ﹤0.01% 1369
2024
Q1 		$554K Sell
5,269
-109
-2% -$9.79K ﹤0.01% 1474
2023
Q4 		$406K Sell
5,378
-49
-0.9% -$3.11K ﹤0.01% 1550
2023
Q3 		$358K Sell
5,427
-57
-1% -$4.26K ﹤0.01% 1545
2023
Q2 		$446K Buy
+5,484
New +$390K ﹤0.01% 1470
2022
Q4 		– Sell
-5,140
Closed -$265K – 1870
2022
Q3 		$265K Buy
+5,140
New +$305K ﹤0.01% 1647
2022
Q2 		– Sell
-2,380
Closed -$205K – 1938
2022
Q1 		$205K Buy
+2,380
New +$196K ﹤0.01% 1806
2016
Q2 		– Sell
-18,799
Closed -$544K – 1582
2016
Q1 		$544K Buy
18,799
+4,606
+32% +$120K ﹤0.01% 1240
2015
Q4 		$430K Sell
14,193
-141,700
-91% -$4.65M ﹤0.01% 1307
2015
Q3 		$5.76M Sell
155,893
-873,650
-85% -$45.1M 0.01% 860
2015
Q2 		$59.6M Buy
1,029,543
+358,862
+54% +$18.3M 0.07% 370
2015
Q1 		$33.2M Buy
670,681
+39,512
+6% +$1.85M 0.04% 536
2014
Q4 		$32M Buy
631,169
+301,742
+92% +$15.8M 0.03% 528
2014
Q3 		$19.6M Buy
+329,427
New +$18.4M 0.02% 685

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Neuberger Berman Group's THC Position: Q2 2026 in Review

Neuberger Berman Group increased its Tenet Healthcare (THC) stake by 8.8% in Q2 2026, buying an estimated $654K and bringing the position to 44,006 shares worth $8.23M. The position accounts for 0.01% of the portfolio, ranked #930.

Neuberger Berman Group first reported a position in THC in Q3 2014 and has held it in 22 quarters since. The position peaked at $59.6M in Q2 2015. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Neuberger Berman Group held 44,006 shares of Tenet Healthcare worth $8.23M as of Q2 2026.
  • Neuberger Berman Group bought 3,559 Tenet Healthcare shares in Q2 2026, an estimated $654K.
  • Tenet Healthcare made up 0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #930 holding.
  • Neuberger Berman Group first reported a position in Tenet Healthcare in Q3 2014 and has held it in 22 quarters since.
  • Neuberger Berman Group's Tenet Healthcare position peaked at $59.6M in Q2 2015.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.